E126: Risk Signals, JAKs, and SELECTIVE-ity
Update: 2025-09-08
Description
Covering an interesting but ultimately disappointing post hoc study of multiple upadacitinib trials in RA. Initially some hope for clarity in the "Do JAKs cause all the badness?" questions, but ultimately landing me about where I have been since ORAL-SURVEILLANCE was published
Paper: https://www.sciencedirect.com/science/article/pii/S0003496724423091
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
